HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Brigitte Michelsen Selected Research

Crohn Disease (Crohn's Disease)

1/2023Management of Concomitant Inflammatory Bowel Disease or Uveitis in Patients with Psoriatic Arthritis: An Updated Review Informing the 2021 GRAPPA Treatment Recommendations.
12/2021Effect of Therapeutic Drug Monitoring vs Standard Therapy During Maintenance Infliximab Therapy on Disease Control in Patients With Immune-Mediated Inflammatory Diseases: A Randomized Clinical Trial.
1/2021Effect of Therapeutic Drug Monitoring vs Standard Therapy During Infliximab Induction on Disease Remission in Patients With Chronic Immune-Mediated Inflammatory Diseases: A Randomized Clinical Trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Brigitte Michelsen Research Topics

Disease

19Psoriatic Arthritis
04/2024 - 01/2017
12Axial Spondyloarthritis
04/2024 - 01/2020
10Pain (Aches)
01/2024 - 01/2018
8Rheumatoid Arthritis
01/2022 - 01/2017
7Ankylosing Spondylitis
04/2024 - 01/2020
7Fatigue
01/2024 - 01/2020
4Arthritis (Polyarthritis)
02/2023 - 01/2022
4Necrosis
11/2021 - 01/2017
3Ulcerative Colitis
01/2023 - 01/2021
3Crohn Disease (Crohn's Disease)
01/2023 - 01/2021
2Psoriasis (Pustulosis Palmaris et Plantaris)
12/2021 - 01/2021
2Inflammation (Inflammations)
05/2021 - 11/2020
2Arthralgia (Joint Pain)
05/2021 - 11/2017
1Rheumatic Diseases (Rheumatism)
02/2023
1Non-Radiographic Axial Spondyloarthritis
01/2023
1Infections
01/2023
1Uveitis
01/2023
1Neoplasms (Cancer)
12/2022
1Spondylarthritis (Spinal Arthritis)
11/2022
1Acute Coronary Syndrome
01/2022
1Joint Diseases (Joint Disease)
01/2020

Drug/Important Bio-Agent (IBA)

18Tumor Necrosis Factor InhibitorsIBA
05/2024 - 01/2020
13Antirheumatic Agents (DMARD)IBA
01/2023 - 01/2017
7C-Reactive ProteinIBA
04/2024 - 01/2018
7secukinumabIBA
01/2024 - 01/2020
4ametantrone (HAQ)IBA
01/2024 - 10/2022
3Adalimumab (Humira)FDA Link
01/2023 - 01/2023
2Prostaglandins AIBA
01/2024 - 11/2022
2Leukocyte L1 Antigen Complex (Calgranulin)IBA
08/2022 - 05/2021
2ORALIT (ORS)IBA
01/2022 - 01/2021
2Infliximab (Remicade)FDA Link
12/2021 - 01/2021
21- hydroxy- 5,8- bis(2- ((2- hydroxyethyl)amino)ethylamino)- 9,10- anthracenedioneIBA
05/2021 - 01/2020
2Methotrexate (Mexate)FDA LinkGeneric
11/2017 - 01/2017
1Ustekinumab (CNTO 1275)FDA Link
01/2023
1tofacitinibIBA
01/2023
1apremilastIBA
01/2023
1ixekizumabIBA
01/2023
1Etanercept (Enbrel)FDA Link
01/2023
1Abatacept (Orencia)FDA Link
01/2023
1insulin receptor-related receptor (IRR)IBA
12/2022
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2022
1AntibodiesIBA
08/2022
1HLA-B27 Antigen (HLA B27 Antigen)IBA
01/2022
1Interleukin-17 (Interleukin 17)IBA
01/2022
1Rheumatoid FactorIBA
11/2020
1Anti-Citrullinated Protein AntibodiesIBA
11/2020
1golimumabFDA Link
01/2020
1Acute-Phase Proteins (Acute-Phase Protein)IBA
11/2017

Therapy/Procedure

5Therapeutics
01/2023 - 11/2020